Wenyan Han Selected Research

amberlite XAD 7

7/2018

Computer-aided design of short peptide ligands targeting tumor necrosis factor-alpha for adsorbent applications.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wenyan Han Research Topics

Disease

9	Neoplasms (Cancer) 10/2022 - 01/2014
2	Liver Failure 12/2021 - 02/2017
1	Neurodevelopmental Disorders 11/2022
1	Breast Neoplasms (Breast Cancer) 12/2021
1	Necrosis 12/2021
1	Hyperbilirubinemia 12/2021
1	Obesity 10/2020
1	Infectious Arthritis (Septic Arthritis) 10/2020
1	Body Weight (Weight, Body) 10/2020
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Dehydration (Water Stress) 01/2019
1	Sepsis (Septicemia) 07/2018
1	Stomach Neoplasms (Stomach Cancer) 10/2017
1	Epilepsy (Aura) 01/2017
1	Mycoses (Diseases, Fungus) 11/2016
1	Lymphatic Metastasis 01/2014

Drug/Important Bio-Agent (IBA)

4	Peptides (Polypeptides)IBA 10/2022 - 08/2017
3	Proteins (Proteins, Gene)FDA Link 01/2019 - 01/2014
2	Pharmaceutical PreparationsIBA 10/2022 - 10/2017
2	Antineoplastic Agents (Antineoplastics)IBA 01/2019 - 08/2017
1	gamma-Aminobutyric Acid (GABA)IBA 11/2022
1	LipidsIBA 10/2022
1	Nucleic AcidsIBA 10/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2021
1	CytokinesIBA 12/2021
1	Polyvinyl AlcoholIBA 12/2021
1	BilirubinIBA 12/2021
1	Messenger RNA (mRNA)IBA 12/2021
1	Heparin (Liquaemin)FDA LinkGeneric 12/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2020
1	Biological ProductsIBA 01/2019
1	EnzymesIBA 01/2019
1	TeaIBA 01/2019
1	Cyclin D1IBA 01/2019
1	Death Domain ReceptorsIBA 01/2019
1	Indicators and Reagents (Reagents)IBA 08/2018
1	amberlite XAD 7IBA 07/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2017
1	Polystyrenes (Polystyrene)IBA 02/2017
1	ferric citrate iron reductase (ferric-chelate reductase)IBA 01/2017
1	jasmonic acid (jasmonate)IBA 11/2016
1	Caffeine (No Doz)FDA LinkGeneric 11/2016
1	ParaffinIBA 01/2014
1	Tumor Protein p73IBA 01/2014

Therapy/Procedure

3	Therapeutics 12/2021 - 10/2017
3	Hemoperfusion 12/2021 - 02/2017
1	Microspheres (Microsphere) 12/2021
1	Drug Therapy (Chemotherapy) 10/2017